Andrology, an esteemed journal published by WILEY, is dedicated to advancing the field of reproductive health and medicine. With an ISSN of 2047-2919, this journal spans critical topics in andrology, urology, and endocrinology, reflecting its strong commitment to scholarly excellence and innovation. As a Q1 ranked journal in both Reproductive Medicine and Urology, Andrology boasts impressive Scopus rankings, standing at 6th in Reproductive Medicine and 8th in Urology, placing it in the top 10% of its field. The journal is accessible as an Open Access platform, ensuring that valuable research findings are available to a broader audience. With significant impact evidenced by its categorization in Q2 for Endocrinology and Diabetes and Metabolism, Andrology serves as an essential resource for researchers, clinicians, and students alike, supporting the continued advancement of knowledge and practice in male reproductive health.

ZYGOTE is a prominent academic journal published by Cambridge University Press, focusing on the fields of Cell Biology and Developmental Biology. Established in 1993, this journal serves as a platform for high-quality research that advances our understanding of the complex processes that underlie cellular and developmental mechanisms. While currently classified in the Q4 quartile for both fields, ZYGOTE provides valuable insights and contributions from early-stage research to established studies, making it a noteworthy resource for researchers and professionals seeking to explore innovative developments in biology. Although it does not offer open access, the journal maintains rigorous peer-review standards to ensure the integrity and relevance of the published work. With its ongoing commitment to disseminating knowledge, ZYGOTE plays a significant role in the scientific community, fostering collaboration and inspiration among students, researchers, and professionals alike.

Fertility and Sterility is a prestigious peer-reviewed journal dedicated to the fields of obstetrics, gynecology, and reproductive medicine. Published by Elsevier Science Inc, this journal has been a cornerstone of scientific discourse since its inception in 1950 and is set to continue its influential coverage of cutting-edge research until 2024. Boasting an impressive impact factor, Fertility and Sterility is ranked among the top-tier journals in its category, holding Q1 status in both Obstetrics and Gynecology and Reproductive Medicine. With Scopus rankings placing it in the 97th and 96th percentiles respectively, the publication serves as a vital resource for researchers, clinicians, and students who seek to advance their understanding of fertility issues and reproductive health. Although it does not currently offer open access options, the journal remains committed to disseminating high-quality research and innovative solutions to the complex challenges in reproduction, empowering professionals and scholars to make meaningful contributions in their fields.

The International Journal of Fertility & Sterility, published by ROYAN Institute, is a leading academic platform dedicated to advancing knowledge in the fields of obstetrics, gynecology, and reproductive medicine. With an ISSN of 2008-076X and an E-ISSN of 2008-0778, this Open Access journal has been making significant contributions to the scientific community since its inception in 2007. Based in Tehran, Iran, the journal showcases rigorous research and promotes interdisciplinary collaboration, addressing critical topics related to fertility, sterility, and reproductive health. As of 2023, it holds an impressive Q2 ranking in Obstetrics and Gynecology and a Q3 ranking in Reproductive Medicine, underscoring its relevance and impact in the academic sphere, with Scopus ranks placing it at #67 in Obstetrics and Gynecology and #32 in Reproductive Medicine. The journal's commitment to accessibility and quality is reflected in its global readership, making it an essential resource for researchers, healthcare professionals, and students seeking to enhance their understanding of fertility issues and reproductive technologies.

Reproductive Biomedicine Online, published by Elsevier, is a leading peer-reviewed journal that has established itself as a pivotal resource in the fields of Developmental Biology, Obstetrics and Gynecology, and Reproductive Medicine. With an impressive Impact Factor and a Q1 ranking in its respective disciplines as of 2023, this journal provides a platform for innovative research and comprehensive reviews that contribute to advancements in reproductive healthcare. The journal boasts rigorous Scopus rankings, placing it within the top tiers of its categories, which underscores its significance in shaping contemporary biomedical inquiry. Although not open access, it remains widely accessible through institutional subscriptions, making its wealth of knowledge available to researchers, clinicians, and students alike. Since its inception in 2000, Reproductive Biomedicine Online has been committed to fostering a deeper understanding of reproductive processes and biomedicine, ensuring that its content remains relevant and impactful in addressing challenges in reproductive health, thereby championing exceptional scientific discourse.

Reproductive and Developmental Medicine is a pioneering open-access journal dedicated to advancing knowledge in the fields of reproductive medicine and developmental biology. Published by LIPPINCOTT WILLIAMS & WILKINS, the journal serves as a platform for researchers, clinicians, and graduate students alike, fostering collaboration and dissemination of innovative research findings. With an ISSN of 2096-2924 and E-ISSN 2589-8728, it has established a significant presence in the academic community since its inception in 2017. The journal is indexed in Scopus and achieved a category quartile ranking of Q3 in Obstetrics and Gynecology and Q4 in Reproductive Medicine as of 2023, highlighting its importance as a resource for cutting-edge studies and reviews in these vital areas. The journal's open-access model ensures that research is readily available to scholars and practitioners worldwide, thus enhancing the global discourse in reproductive health and development. This makes Reproductive and Developmental Medicine an invaluable resource for those dedicated to improving outcomes in obstetrics, gynecology, and reproductive health.

Gynakologische Endokrinologie is a pivotal journal published by SPRINGER HEIDELBERG, dedicated to advancing the fields of endocrinology, obstetrics, gynecology, reproductive medicine, and pediatrics. With an ISSN of 1610-2894, this journal serves as a valuable platform for researchers and practitioners to disseminate their findings and explore emerging trends and treatments in the realm of women's health and endocrine disorders. Though currently positioned in the Q4 quartile across relevant categories, its mission is to foster scholarly discourse that bridges gaps in knowledge and enhances clinical practices. With a commitment to quality research, it provides a forum for innovative studies and case reports that could influence future healthcare strategies. Positioned in Germany, Gynakologische Endokrinologie aims to cater to a global audience, enhancing knowledge and collaboration in critical areas impacting women's health and hormone-related conditions.

Reproduction and Fertility is a premier academic journal published by BIOSCIENTIFICA LTD, dedicated to advancing knowledge in the fields of reproductive sciences, obstetrics, gynecology, and related areas. Established with a focus on delivering high-quality research, this journal has quickly ascended in prominence, achieving a commendable Q2 ranking in multiple categories, including Embryology, Obstetrics and Gynecology, Reproductive Medicine, and Urology, as of 2023. With an E-ISSN of 2633-8386, Reproduction and Fertility aims to provide a valuable platform for researchers, professionals, and students alike, offering insights into the latest discoveries and innovations in reproductive health. Although currently not an open-access journal, it remains committed to disseminating important findings that can influence clinical practices and policy-making worldwide. Operating from its headquarters in Bristol, United Kingdom, the journal serves as an essential resource for anyone invested in understanding and improving reproductive health outcomes through rigorous academic research.

The Journal of Assisted Reproduction and Genetics, published by Springer/Plenum Publishers, serves as a pivotal platform for innovative research and advancements in the fields of reproductive medicine, genetics, and developmental biology. With an impact factor that positions it within the upper echelon of its categories—including Q1 rankings in Obstetrics and Gynecology and Reproductive Medicine—this journal plays a critical role in disseminating high-quality, peer-reviewed studies that significantly influence clinical practices and research directions. Renowned for its commitment to enhancing understanding in areas such as assisted reproductive technologies, genetic screening, and reproductive health, the journal attracts contributions from leading experts worldwide. With a broad scope encompassing original research, case studies, and comprehensive reviews, the Journal of Assisted Reproduction and Genetics continues to be an essential resource for researchers, healthcare professionals, and students dedicated to the advancement of reproductive sciences.

Systems Biology in Reproductive Medicine, published by Taylor & Francis Inc, is a leading journal dedicated to advancing the understanding of reproductive health through the lens of systems biology. With an ISSN of 1939-6368 and an E-ISSN of 1939-6376, this journal provides an essential platform for researchers and practitioners in the fields of reproductive medicine and urology. Although it primarily operates under a subscription model, the journal remains a valuable resource, featuring cutting-edge research and comprehensive reviews that reflect its Q2 ranking in both Reproductive Medicine and Urology categories. Recognized for its impactful research, indicated by its ranks of #37/120 and #30/90 in Scopus for Urology and Reproductive Medicine respectively, it addresses complex biological systems and their implications in reproductive health. Aimed at facilitating interdisciplinary collaboration, the journal covers a wide array of topics relevant to both the medical and scientific communities, making it an indispensable resource for ongoing education and advancements in reproductive medicine.